Log in to save to my catalogue

Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase

Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5910822

Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase

About this item

Full title

Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase

Publisher

United States: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2018-04, Vol.115 (16), p.E3741-E3748

Language

English

Formats

Publication information

Publisher

United States: National Academy of Sciences

More information

Scope and Contents

Contents

Inactivation of the retinoblastoma gene (RB1) product, pRB, is common in many human cancers. Targeting downstream effectors of pRB that are central to tumorigenesis is a promising strategy to block the growth of tumors harboring loss-of-function RB1 mutations. One such effector is retinoblastoma-binding protein 2 (RBP2, also called JARID1A or KDM5A...

Alternative Titles

Full title

Autochthonous tumors driven by Rb1 loss have an ongoing requirement for the RBP2 histone demethylase

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5910822

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5910822

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1716029115

How to access this item